|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30,550 KRW | -0.81% |
|
-0.81% | -14.06% |
| Mar. 14 | JW Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Jan. 22 | CJ Logistics Secures Distribution Deal for JW Pharm's Intravenous Solutions | MT |
JW Pharmaceutical Corporation reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was KRW 1,388.04 million compared to KRW 2,942.45 million a year ago. Net income was KRW 9,584.03 million compared to KRW 4,032.2 million a year ago.
Basic earnings per share from continuing operations was KRW 394.1748 compared to KRW 167.9612 a year ago. Basic earnings per share was KRW 394.1748 compared to KRW 167.9612 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -14.06% | 520M | |
| +30.38% | 684B | |
| +26.51% | 568B | |
| -4.36% | 361B | |
| +19.30% | 329B | |
| +3.73% | 284B | |
| +16.70% | 240B | |
| +8.78% | 208B | |
| -7.93% | 200B | |
| +7.68% | 166B |
JW PHARMACEUTICAL CORPORATION 
